Compassionate Use of Aldoxorubicin in Sarcoma Patients Chemotherapy

Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery

NCT00098579 ·Status: COMPLETED ·Phase: PHASE1

Irinotecan (Camptosar) in Patients With Advanced Sarcomas

NCT00509860 ·Status: COMPLETED ·Phase: PHASE2

Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma

NCT00410462 ·Status: UNKNOWN ·Phase: PHASE2

Study of Topical SOR007 Ointment for Cutaneous Metastases

NCT03101358 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma

NCT03056001 ·Status: COMPLETED ·Phase: PHASE2

A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions

NCT06308419 ·Status: RECRUITING ·Phase: PHASE1

A Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue Sarcoma

NCT05100628 ·Status: TERMINATED ·Phase: PHASE1

Localized High-Risk Soft Tissue Sarcomas Of The Extremities And Trunk Wall In Adults: An Integrating Approach Comprising Standard Vs Histotype-Tailored Neoadjuvant Chemotherapy

NCT01710176 ·Status: COMPLETED ·Phase: PHASE3

Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

NCT00041249 ·Status: COMPLETED ·Phase: PHASE2

Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid Tumors

NCT00004079 ·Status: COMPLETED ·Phase: PHASE1

Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)

NCT00093080 ·Status: COMPLETED ·Phase: PHASE2

Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Soft Tissue Sarcoma

NCT01296659 ·Status: WITHDRAWN ·Phase: PHASE1

CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

NCT00017446 ·Status: UNKNOWN ·Phase: PHASE2

Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma

NCT00245102 ·Status: COMPLETED ·Phase: PHASE2

Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma

NCT01303341 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma

NCT00659360 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Patients With RAD001 With Progressive Sarcoma

NCT00767819 ·Status: COMPLETED ·Phase: PHASE2

Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)

NCT00330421 ·Status: COMPLETED ·Phase: PHASE2

Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma

NCT00734526 ·Status: TERMINATED ·Phase: PHASE1

Sorafenib and Dacarbazine in Soft Tissue Sarcoma

NCT00837148 ·Status: COMPLETED ·Phase: PHASE2

Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma

NCT02050919 ·Status: COMPLETED ·Phase: PHASE2

Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

NCT00003212 ·Status: COMPLETED ·Phase: PHASE3

Taxotere/Temodar/Cisplatin Study in Melanoma Patients

NCT00527761 ·Status: COMPLETED ·Phase: PHASE1

A Study of XmAb23104 in People With Sarcoma

NCT05879185 ·Status: TERMINATED ·Phase: PHASE2

Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors

NCT00088595 ·Status: COMPLETED ·Phase: PHASE2